BIO-key International Inc. (NASDAQ:BKYI) Sees Large Decrease in Short Interest

BIO-key International Inc. (NASDAQ:BKYI) saw a large decline in short interest in the month of April. As of April 15th, there was short interest totaling 144,429 shares, a decline of 20.5% from the March 31st total of 181,682 shares. Based on an average trading volume of 89,058 shares, the days-to-cover ratio is presently 1.6 days. Approximately 1.4% of the shares of the company are sold short.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on BKYI shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of BIO-key International in a research note on Monday, April 20th. Wall Street Zen raised BIO-key International to a “sell” rating in a report on Saturday, January 3rd. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, BIO-key International has an average rating of “Sell”.

BIO-key International Price Performance

Shares of BIO-key International stock traded up $0.34 during trading on Friday, reaching $5.33. 29,801 shares of the company’s stock were exchanged, compared to its average volume of 248,149. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.13 and a current ratio of 1.26. BIO-key International has a 1-year low of $4.05 and a 1-year high of $19.70. The company has a market cap of $57.83 million, a P/E ratio of -7.61 and a beta of 0.50. The firm’s 50-day moving average price is $6.04 and its 200 day moving average price is $6.70.

BIO-key International (NASDAQ:BKYI) last posted its quarterly earnings results on Tuesday, March 31st. The technology company reported ($1.90) EPS for the quarter, missing analysts’ consensus estimates of ($0.70) by ($1.20). BIO-key International had a negative return on equity of 67.43% and a negative net margin of 75.32%.The business had revenue of $1.24 million for the quarter, compared to analyst estimates of $2.20 million.

Hedge Funds Weigh In On BIO-key International

An institutional investor recently raised its position in BIO-key International stock. Geode Capital Management LLC boosted its position in BIO-key International Inc. (NASDAQ:BKYI) by 49.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 48,892 shares of the technology company’s stock after purchasing an additional 16,271 shares during the period. Geode Capital Management LLC owned 0.45% of BIO-key International worth $26,000 at the end of the most recent quarter. 26.51% of the stock is currently owned by institutional investors and hedge funds.

BIO-key International Company Profile

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.